High risky behaviors among intravenous drug users in Isfahan, Iran: A study for hepatitis c harm reduction programs

International Journal of Preventive Medicine

Volumn 3, Issue 4, 2012, Pages

  Hassannejad, Razieh ^a   Kassaian, Nazila ^a   Ataei, Behrooz ^a   Adibi, Peyman ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis C virus; High risky behaviors; Intravenous drug users

Indexed keywords

ADULT; ARTICLE; COMMUNITY PROGRAM; CONDOM; CROSS-SECTIONAL STUDY; FEMALE; HARM REDUCTION; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HOMOSEXUALITY; HUMAN; ILLEGITIMACY; INTERVIEW; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; PROSTITUTION; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUALITY; UNSAFE SEX; VIRUS TRANSMISSION;

EID: 84865208479     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Jarlais DCD, Semaan S. Interventions to reduce the sexual risk behaviour of injecting drug users. Int J Drug Policy 2005;16:58-66.
2. Rhodes T. Risk theory in epidemic times: Sex, drugs and the social organisation of 'risk behaviour'. Sociol Health Illn 1997;19:208-27.
3. Razzaghi E, Rahimi A, Hosseni M, Madani S, Chatterjee A. Rapid Situation Assessment (RSA) of drug abuse in Iran. Prevention Department, State Welfare Organization, Ministry of Health, IR of Iran and United Nations International Drug Control Program. 1999:.
4. Mirahmadizadeh A, Majdzadeh R, Mohammad K, Forouzanfar M. Prevalence of HIV and hepatitis C virus infections and related behavioral determinants among injecting drug users of drop-in centers in Iran. Iranian Red Crescent Medical Journal IRCMJ 2009;11:325-9.
5. Javadi AA, Ataei B, Pourahmad M. The relationship between frequency and duration of imprisonment and the prevalence of HBsAg, Anti HCV and HIV antibody seropositivity in Iranian prisoners. J Med Council IRI 2007; 24(4):358-364.
6. Day C, Nassirimanesh B, Shakeshaft A, Dolan K. Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran. Harm Reduct J 2006;3:2.
7. Zamani S, Kihara M, Gouya MM, Vazirian M, Nassirimanesh B, Ono-Kihara M, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr 2006;42:342-6.
8. Holtzman D, Barry V, Ouellet LJ, Jarlais DC, Vlahov D, Golub ET, et al. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med 2009;49:68-73.
9. Schumacher CM, Go VF, Van Nam L, Latkin CA, Bergenstrom A, Celentano DD, et al. Social injecting and other correlates of high-risk sexual activity among injecting drug users in northern Vietnam. Int J Drug Policy 2009;20:352-6.
10. Tran TN, Detels R, Hien NT, Long HT, Nga PT. Drug use, sexual behaviours and practices among male drug users in Hanoi, Vietnam-a qualitative study. Int J Drug Policy 2004;15:182-8.
11. Todd CS, Abed AM, Strathdee SA, Scott PT, Botros BA, Safi N, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis 2007;13:1327-31.
12. Rahbar AR, Rooholamini S, Khoshnood K. Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhad, Iran. Int J Drug Policy 2004;15:151-5.